Zachary Zimmerman, Forge Therapeutics CEO
Forge spinoff Blacksmith Medicines merges back into company two years after launch, but details are slim
Blacksmith Medicines and Forge Therapeutics announced Monday that the companies are merging only a year after Blacksmith launched as a spinout …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
